5VM
CLDX icon

5AM Venture Management’s Celldex Therapeutics CLDX Stock Holding History

5AM Venture Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Hold
497,270
– – 4.38% 9
2025
Q4 		$13.5M Hold
497,270
– – 4.25% 10
2025
Q3 		$12.9M Hold
497,270
– – 4.71% 11
2025
Q2 		$10.1M Hold
497,270
– – 3.89% 11
2025
Q1 		$9.03M Hold
497,270
– – 3.41% 12
2024
Q4 		$12.6M Hold
497,270
– – 3% 16
2024
Q3 		$16.9M Hold
497,270
– – 3.49% 11
2024
Q2 		$18.4M Hold
497,270
– – 4.12% 5
2024
Q1 		$20.9M Hold
497,270
– – 4.67% 5
2023
Q4 		$19.7M Buy
497,270
+187,000
+60% +$5.5M 5.23% 4
2023
Q3 		$8.54M Hold
310,270
– – 2.46% 12
2023
Q2 		$10.5M Buy
+310,270
New +$10.5M 2.62% 10

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return